title: Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
authors.forename: Carlos
authors.initials: C
authors.lastname: Solano
authors.forename: Isabel
authors.initials: I
authors.lastname: Benet
authors.forename: María José
authors.initials: MJ
authors.lastname: Remigia
authors.forename: Rafael
authors.initials: R
authors.lastname: de la Cámara
authors.forename: Beatriz
authors.initials: B
authors.lastname: Muñoz-Cobo
authors.forename: Elisa
authors.initials: E
authors.lastname: Costa
authors.forename: María Ángeles
authors.initials: MÁ
authors.lastname: Clari
authors.forename: Dayana
authors.initials: D
authors.lastname: Bravo
authors.forename: Paula
authors.initials: P
authors.lastname: Amat
authors.forename: David
authors.initials: D
authors.lastname: Navarro
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic / Q000379:methods; D010865:Pilot Projects; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D014184:Transplantation, Homologous; D019562:Viral Load; D014766:Viremia / Q000209:etiology / Q000276:immunology / Q000517:prevention & control
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral